AstraZeneca Wants to Conceal Seroquel Information
Pharmaceutical companies willingly settle court cases for hundreds of millions of dollars–even billions of dollars–to keep the truth about their drugs under seal.
Biederman J & J Risperdal Documents
A group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing division-provide a bird’s eye view of collusion between the drug giant and Harvard’s leading child psychiatrist, Dr. Joseph Biederman, and one of Harvard’s premier teaching hospitals, Massachusetts General Hospital.
Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle Approach
"The committee’s concerns are part of a growing chorus of complaints about the increasing use of antipsychotic medicines in children and teenagers.
Grassley Probes COI at American Psychiatric Association
Sen. Grassley is peeling away psychiatry’s layers of deception about the efficacy and safety of its treatments: "I have come to understand that money from the pharmaceutical industry can shape the practices of nonprofit organizations that purport to be independent in their viewpoints and actions."
Letter of Complaint Re: FDA Double Agent
A follow-up letter to FDA Commissioner, Andrew vonEschenbach RE: Thomas Laughren, FDA’s ‘s Director of Psychiatry Products who has been actively promoting psychotropic drugs–even penning his name to ghostwritten industry-sponsored articles and consensus panels.
Letter of Complaint to FDA Commissioner, 2007
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion.
FDA Set to Approve Antibiotic for Cattle That Poses Catastrophic Threat_WashPost
Overshadowing all other health related news, a front page report in The Washington Post and the just released Breckenridge report evaluating FDA's abysmal performance on drug safety, http://ahrp.blogspot.com/2007/03/latest-report-blasts-fda-bungling-drug.html require Congressional action.
AACAP President Disingenuous RE: Psychiatric Drugs that Killed 4-year old
This young child represents millions of children in the United States who are falling prey to licensed, but irresponsible prescribers of toxic drugs.
Activists Take on Eli Lilly Over Off-Label Marketing & Harm Caused by Zyprexa
The deceptive marketing of antipsychotic drugs has prompted new advocacy group to launch "The Just Say "Know" to Prescription Drugs Campaign." Its goal is to get one million people to stop and reevaluate the medications they are taking.
4-year old Rebecca Riley,a Casualty of Psychiatric “Treatment”_BostonGlobe_NYT
“To me one of the miracle of children’s brains is that we don’t see more harm from these treatments.”
Court Ruling: Injunction on Release of Zyprexa Documents
A federal Judge of the Eastern District (Brooklyn) issued a ruling upholding a seal on documents that contain evidence linking Zyprexa, Eli Lilly's antipsychotic drug to diabetes
Zyprexa Documents Court Ruling
Despite Lilly's efforts to suppress the documents, they are available on internet websites.
Judge Jack Weinstein rejected Lilly's effort to seek a court injunction against internet posting
of the documents.